Unique ID issued by UMIN | C000000311 |
---|---|
Receipt number | R000000403 |
Scientific Title | Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology; TRUTH Study (Kanagawa PTCA Conference Regression Study 5; KPCR5) |
Date of disclosure of the study information | 2006/01/25 |
Last modified on | 2012/08/21 11:23:52 |
Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology; TRUTH Study (Kanagawa PTCA Conference Regression Study 5; KPCR5)
Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology; TRUTH Study (Kanagawa PTCA Conference Regression Study 5; KPCR5)
Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology; TRUTH Study (Kanagawa PTCA Conference Regression Study 5; KPCR5)
Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology; TRUTH Study (Kanagawa PTCA Conference Regression Study 5; KPCR5)
Japan |
Patients with stable or unstable angina
Medicine in general | Cardiology |
Others
NO
To investigate the effect of lipid-lowering therapy with statin (pitavastatin or pravastatin) on tissue characteristics of coronary plaque, lipid levels, and inflammatory markers in patients with stable or unstable angina
Efficacy
Change of tissue characteristics in coronary plaque evaluated by intravascular ultrasound (IVUS) with Virtual Histology
Interventional
Parallel
Randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
pitavastain group
pravastatin group
20 | years-old | <= |
Not applicable |
Male and Female
Patients with stable or unstable angina received PCI whose LDL-cholesterollevel is above 140mg/dL
1)Patients currently medicated with statins or other lipid lowering therapy 2)Patients meeting the contraindications or relative contraindications for pitavastatin and pravastatin 3)Patients with hepatic disorder (AST or ALT greater than 2.5 times of the normal upper limits) 4)Patients with renal dysfunction (serum creatinine 2.0mg/dL or higher) 5)Patients with a history of severe muscular disorder or increased CK (CPK) greater than 2.5 times of the normal upper limit 6)Patients with acute myocardial infarction occurred within 24 hours 7)Patients failed to PCI 8)Patients with cerebrovascular accident occurred within 1 month 9)Patients with concurrent or a history of malignant disease within 5 years 10)Patients receiving LDL apheresis 11)Patients with homozygous familial hypercholesterolemia 12)Patients requiring the following prohibited concomitant drugs 13)Drug abusers 14)Patients participating in other studies 15)Patients ineligible for the study determined by physicians
160
1st name | |
Middle name | |
Last name | Ichiro Michishita |
Yokohama Sakae Kyosai Hospital
Department of Internal medicine, Division of Cardiology
132 Katsura-cho, Sakae-ku, Yokohama, 247-8581, JAPAN
045-891-2171
1st name | |
Middle name | |
Last name | Tsuyoshi Nozue |
Yokohama Sakae Kyosai Hospital
Department of Internal medicine, Division of Cardiology
yk411015@fsinet.or.jp
Kanagawa PTCA Conference
Japan Heart Foundation
Non profit foundation
NO
2006 | Year | 01 | Month | 25 | Day |
Published
Completed
2005 | Year | 11 | Month | 30 | Day |
2005 | Year | 12 | Month | 01 | Day |
2008 | Year | 12 | Month | 01 | Day |
2008 | Year | 12 | Month | 01 | Day |
2009 | Year | 03 | Month | 01 | Day |
2009 | Year | 03 | Month | 01 | Day |
2006 | Year | 01 | Month | 25 | Day |
2012 | Year | 08 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000403